About This Event

Reimbursement and Contracting

Now in its sixth year, CBI’s Reimbursement and Contracting provides a platform for bio/pharmaceutical manufacturers looking to unravel complexities associated with reimbursement, pricing strategies and commercial contracting. As pricing pressures and competition continue to mount, reimbursement, pricing and contract teams must navigate evolving landscapes to developing competitive pricing strategies. Join experts to discuss the latest on patient access, reform, ACOs, IDNs, health insurance exchanges, Medicare Part D, 340B and much more!
Now in its sixth year, CBI’s Reimbursement and Contracting provides a platform for bio/pharmaceutical manufacturers looking to unravel complexities associated with reimbursement, pricing strategies and commercial contracting. As pricing pressures and competition continue to mount, reimbursement, pricing and contract teams must navigate evolving landscapes to developing competitive pricing strategies. Join experts to discuss the latest on patient access, reform, ACOs, IDNs, health insurance exchanges, Medicare Part D, 340B and much more!
Now in its sixth year, CBI’s Reimbursement and Contracting provides a platform for bio/pharmaceutical manufacturers looking to unravel complexities associated with reimbursement, pricing strategies and commercial contracting. As pricing pressures and competition continue to mount, reimbursement, pricing and contract teams must navigate evolving landscapes to developing competitive pricing strategies. Join experts to discuss the latest on patient access, reform, ACOs, IDNs, health insurance exchanges, Medicare Part D, 340B and much more!
Now in its sixth year, CBI’s Reimbursement and Contracting provides a platform for bio/pharmaceutical manufacturers looking to unravel complexities associated with reimbursement, pricing strategies and commercial contracting. As pricing pressures and competition continue to mount, reimbursement, pricing and contract teams must navigate evolving landscapes to developing competitive pricing strategies. Join experts to discuss the latest on patient access, reform, ACOs, IDNs, health insurance exchanges, Medicare Part D, 340B and much more!
Now in its sixth year, CBI’s Reimbursement and Contracting provides a platform for bio/pharmaceutical manufacturers looking to unravel complexities associated with reimbursement, pricing strategies and commercial contracting. As pricing pressures and competition continue to mount, reimbursement, pricing and contract teams must navigate evolving landscapes to developing competitive pricing strategies. Join experts to discuss the latest on patient access, reform, ACOs, IDNs, health insurance exchanges, Medicare Part D, 340B and much more!

About This Event

8th World Conference on Women’s Health and Breast Cancer Conference

“ME Conferences insist participants from all over the universe clock in “8th World Conference On Women’s Health and Breast Cancer” during December 13-14, 2018 in Abu Dhabi, UAE which includes precise keynote, presentations Oral talks, poster presentation, and Exhibitions. The theme of the conference this year is “Exploring Essence of shielding vitality and strength of women Against Breast Cancer” assures an exceptional scientific program promoting many acclaimed and logic tormenting speakers.
Women’s health and Breast Cancer Conference 2018 intent to accommodate excellent health and health maintenance to juvenile girls and women, with a target on the interception, analysis and Directorate of productivity disarrangement and disease of gynecological and breast origin, as well as allied ancestral, morbid physiology, hygienic, proven clinical declaration.”
“ME Conferences insist participants from all over the universe clock in “8th World Conference On Women’s Health and Breast Cancer” during December 13-14, 2018 in Abu Dhabi, UAE which includes precise keynote, presentations Oral talks, poster presentation, and Exhibitions. The theme of the conference this year is “Exploring Essence of shielding vitality and strength of women Against Breast Cancer” assures an exceptional scientific program promoting many acclaimed and logic tormenting speakers.
Women’s health and Breast Cancer Conference 2018 intent to accommodate excellent health and health maintenance to juvenile girls and women, with a target on the interception, analysis and Directorate of productivity disarrangement and disease of gynecological and breast origin, as well as allied ancestral, morbid physiology, hygienic, proven clinical declaration.”
“ME Conferences insist participants from all over the universe clock in “8th World Conference On Women’s Health and Breast Cancer” during December 13-14, 2018 in Abu Dhabi, UAE which includes precise keynote, presentations Oral talks, poster presentation, and Exhibitions. The theme of the conference this year is “Exploring Essence of shielding vitality and strength of women Against Breast Cancer” assures an exceptional scientific program promoting many acclaimed and logic tormenting speakers.
Women’s health and Breast Cancer Conference 2018 intent to accommodate excellent health and health maintenance to juvenile girls and women, with a target on the interception, analysis and Directorate of productivity disarrangement and disease of gynecological and breast origin, as well as allied ancestral, morbid physiology, hygienic, proven clinical declaration.”

About This Event

International conference on Neonatology and Pediatrics 2018

We are organising an International Conference on Neonatology and Pediatrics 2018 on November 19th and 20th 2018 at Las Vegas, USA so we are inviting you to be the media partner for our conference.
We are organising an International Conference on Neonatology and Pediatrics 2018 on November 19th and 20th 2018 at Las Vegas, USA so we are inviting you to be the media partner for our conference.
We are organising an International Conference on Neonatology and Pediatrics 2018 on November 19th and 20th 2018 at Las Vegas, USA so we are inviting you to be the media partner for our conference.
We are organising an International Conference on Neonatology and Pediatrics 2018 on November 19th and 20th 2018 at Las Vegas, USA so we are inviting you to be the media partner for our conference.
We are organising an International Conference on Neonatology and Pediatrics 2018 on November 19th and 20th 2018 at Las Vegas, USA so we are inviting you to be the media partner for our
We are organising an International Conference on Neonatology and Pediatrics 2018 on November 19th and 20th 2018 at Las Vegas, USA so we are inviting you to be the media partner for our conference.
We are organising an International Conference on Neonatology and Pediatrics 2018 on November 19th and 20th 2018 at Las Vegas, USA so we are inviting you to be the media partner for our
We are organising an International Conference on Neonatology and Pediatrics 2018 on November 19th and 20th 2018 at Las Vegas, USA so we are inviting you to be the media partner for our conference.
We are organising an International Conference on Neonatology and Pediatrics 2018 on November 19th and 20th 2018 at Las Vegas, USA so we are inviting you to be the media partner for our
We are organising an International Conference on Neonatology and Pediatrics 2018 on November 19th and 20th 2018 at Las Vegas, USA so we are inviting you to be the media partner for our conference.

About This Event

7th Annual Pharmacy Benefit Compliance Congress

Update on State and Federal Pharmacy Regulations
Now in its 7th year, CBI’s Pharmacy Benefit Compliance Congress returns with robust content focusing on the complex legal and compliance nuances associated with managing pharmacy benefits.
Update on State and Federal Pharmacy Regulations
Now in its 7th year, CBI’s Pharmacy Benefit Compliance Congress returns with robust content focusing on the complex legal and compliance nuances associated with managing pha”Update on State and Federal Pharmacy Regulations
Now in its 7th year, CBI’s Pharmacy Benefit Compliance Congress returns with robust content focusing on the complex legal and compliance nuances associated with managing pharmacy benefits.
“rmacy benefits.

Update on State and Federal Pharmacy Regulations
Now in its 7th year, CBI’s Pharmacy Benefit Compliance Congress returns with robust content focusing on the complex legal and compliance nuances associated with managing pharmacy benefits.
Update on State and Federal Pharmacy Regulations
Now in its 7th year, CBI’s Pharmacy Benefit Compliance Congress returns with robust content focusing on the complex legal and compliance nuances associated with managing pharmacy benefits.
Update on State and Federal Pharmacy Regulations
Now in its 7th year, CBI’s Pharmacy Benefit Compliance Congress returns with robust content focusing on the complex legal and compliance nuances associated with managing pharmacy benefits.

About This Event

Independent Expert Committees

Driven by industry’s leading stakeholders, CBI’s highly acclaimed Endpoint Adjudication conference is going global. With Endpoint as the focal point, this meeting covers all of the critical factors and facets impacting clinical and safety teams. Regardless of your therapeutic area, this event delivers strategic content and concrete takeaways to bring back to your organization. Join CBI’s global community of clinical, safety, and project management professionals at Independent Expert Committees as we collaborate to develop and share best practices for committee selection, streamlining data collection and reporting, navigating data privacy and GDPR and minimizing regulatory approval timelines.
Driven by industry’s leading stakeholders, CBI’s highly acclaimed Endpoint Adjudication conference is going global. With Endpoint as the focal point, this meeting covers all of the critical factors and facets impacting clinical and safety teams. Regardless of your therapeutic area, this event delivers strategic content and concrete takeaways to bring back to your organization. Join CBI’s global community of clinical, safety, and project management professionals at Independent Expert Committees as we collaborate to develop and share best practices for committee selection, streamlining data collection and reporting, navigating data privacy and GDPR and minimizing regulatory approval timelines.
Driven by industry’s leading stakeholders, CBI’s highly acclaimed Endpoint Adjudication conference is going global. With Endpoint as the focal point, this meeting covers all of the critical factors and facets impacting clinical and safety teams. Regardless of your therapeutic area, this event delivers strategic content and concrete takeaways to bring back to your organization. Join CBI’s global community of clinical, safety, and project management professionals at Independent Expert Committees as we collaborate to develop and share best practices for committee selection, streamlining data collection and reporting, navigating data privacy and GDPR and minimizing regulatory approval timelines.
Driven by industry’s leading stakeholders, CBI’s highly acclaimed Endpoint Adjudication conference is going global. With Endpoint as the focal point, this meeting covers all of the critical factors and facets impacting clinical and safety teams. Regardless of your therapeutic area, this event delivers strategic content and concrete takeaways to bring back to your organization. Join CBI’s global community of clinical, safety, and project management professionals at Independent Expert Committees as we collaborate to develop and share best practices for committee selection, streamlining data collection and reporting, navigating data privacy and GDPR and minimizing regulatory approval timelines.

About This Event

8th Annual Interactive Response Technologies in Clinical Trials – IRT 2018

8th Annual Interactive Response Technologies in Clinical Trials – IRT 2018

“The industry is rapidly moving towards end-to-end drug accountability in clinical trials as there is a need to track the receipt of a drug from shipment to dispensing, return and destruction. The IRT continues to gain momentum as a critical component to clinical trial and supply chain strategy, and as the complexity of trials continues to rise, creating efficiencies and optimizing the IRT is paramount.

CBI’s 8th Annual Interactive Response Technologies in Clinical Trials – IRT 2018 unites nearly 200 clinical and supply chain pioneers, and is dedicated to solution-oriented discussions and benchmarking for utilizing this powerful system to inform trial decision-making on both a strategic and operational level. This industry acclaimed meeting continues to be the must attend event of the year”
“The industry is rapidly moving towards end-to-end drug accountability in clinical trials as there is a need to track the receipt of a drug from shipment to dispensing, return and destruction. The IRT continues to gain momentum as a critical component to clinical trial and supply chain strategy, and as the complexity of trials continues to rise, creating efficiencies and optimizing the IRT is paramount.

CBI’s 8th Annual Interactive Response Technologies in Clinical Trials – IRT 2018 unites nearly 200 clinical and supply chain pioneers, and is dedicated to solution-oriented discussions and benchmarking for utilizing this powerful system to inform trial decision-making on both a strategic and operational level. This industry acclaimed meeting continues to be the must attend event of the year”
“The industry is rapidly moving towards end-to-end drug accountability in clinical trials as there is a need to track the receipt of a drug from shipment to dispensing, return and destruction. The IRT continues to gain momentum as a critical component to clinical trial and supply chain strategy, and as the complexity of trials continues to rise, creating efficiencies and optimizing the IRT is paramount.

CBI’s 8th Annual Interactive Response Technologies in Clinical Trials – IRT 2018 unites nearly 200 clinical and supply chain pioneers, and is dedicated to solution-oriented discussions and benchmarking for utilizing this powerful system to inform trial decision-making on both a strategic and operational level. This industry acclaimed meeting continues to be the must attend event of the year”

About This Event

2nd International Conference on Sexually Transmitted Diseases,Infections and AIDS

“PULSUS has the immense pleasure in organising “2nd International Conference on Sexually Transmitted Diseases, Infections and AIDS” during 17-18 of October, 2018 in Las Vegas, USA. This conference is an open platform for Researchers, aspiring students, Directors, Professors, Scientists, Academicians and young researchers of life science department to present their diligent work in front of prominent personalities of the same field.

STD & HIV/AIDS 2018 this year comes up with theme Today’s science and Tomorrow’s Technology in treating Sexually Transmitted Diseases and AIDS. The work and ideas of the educational people can be presented as oral presentations, poster presentations and even as video presentations who are intrigued for a global acknowledgement and to add advancement to human lives from their work. This conference provides wider knowledge in Sexually Transmitted diseases its infections and AIDS thereby providing futuristic approaches to treat them in the near future.”
“PULSUS has the immense pleasure in organising “2nd International Conference on Sexually Transmitted Diseases, Infections and AIDS’’ during 17-18 of October, 2018 in Las Vegas, USA. This conference is an open platform for Researchers, aspiring students, Directors, Professors, Scientists, Academicians and young researchers of life science department to present their diligent work in front of prominent personalities of the same field.

About This Event

Outcomes-Based Contracting

“Life sciences manufacturers are facing heightened pressure from the government and other entities to lower the cost of drugs while improving patient outcomes. In an effort to shift from price-per-volume to high-value care, manufacturers are being tasked with bringing treatments to market with outcomes-based, risk-sharing agreements.

CBI’s 3rd Annual Outcomes-Based Contracting Summit delivers key insights into the process of outlining, structuring and negotiating successful performance and value-based contracts. This conference also provides an excellent platform for manufacturers, payers and providers to discuss the challenges and successes regarding government price reporting, value optimization and price alignment with health outcomes data.”
“Life sciences manufacturers are facing heightened pressure from the government and other entities to lower the cost of drugs while improving patient outcomes. In an effort to shift from price-per-volume to high-value care, manufacturers are being tasked with bringing treatments to market with outcomes-based, risk-sharing agreements.

About This Event

Finance & Accounting for Bioscience Companies

CBI’s Annual Finance & Accounting for Bioscience Companies convenes professionals from growing, innovative life sciences organizations to discuss strategies to implement scalable financial reporting process, mitigate risk and develop lean and efficient finance teams. This meeting hones-in on the unique challenges faced by small and mid-sized biotechs and pharmaceutical companies as they transition from private to public, enter into collaborations, cultivate talent and recognize revenue. Gain strategies to ensure regulatory compliance, train new team members, implement systems and effectively communicate financial performance.
CBI’s Annual Finance & Accounting for Bioscience Companies convenes professionals from growing, innovative life sciences organizations to discuss strategies to implement scalable financial reporting process, mitigate risk and develop lean and efficient finance teams. This meeting hones-in on the unique challenges faced by small and mid-sized biotechs and pharmaceutical companies as they transition from private to public, enter into collaborations, cultivate talent and recognize revenue. Gain strategies to ensure regulatory compliance, train new team members, implement systems and effectively communicate financial performance.
CBI’s Annual Finance & Accounting for Bioscience Companies convenes professionals from growing, innovative life sciences organizations to discuss strategies to implement scalable financial reporting process, mitigate risk and develop lean and efficient finance teams. This meeting hones-in on the unique challenges faced by small and mid-sized biotechs and pharmaceutical companies as they transition from private to public, enter into collaborations, cultivate talent and recognize revenue. Gain strategies to ensure regulatory compliance, train new team members, implement systems and effectively communicate financial performance.
CBI’s Annual Finance & Accounting for Bioscience Companies convenes professionals from growing, innovative life sciences organizations to discuss strategies to implement scalable financial reporting process, mitigate risk and develop lean and efficient finance teams. This meeting hones-in on the unique challenges faced by small and mid-sized biotechs and pharmaceutical companies as they transition from private to public, enter into collaborations, cultivate talent and recognize revenue. Gain strategies to ensure regulatory compliance, train new team members, implement systems and effectively communicate financial performance.

About This Event

Bio/Pharma Forum on the State of Medicare Reform

“CBI’s Bio/Pharma Forum on The State of Medicare Reform is focused on the current healthcare landscape and proposed changes for Medicare. It is critical that pharmaceutical and biotech manufacturers keep abreast of how the changing healthcare and insurance landscape will impact Medicare strategy.

Attend this elite meeting to stay on the cutting-edge of information related to Medicare Part B and D and gain an early outlook to understand the major impact of the proposed changes.”
“CBI’s Bio/Pharma Forum on The State of Medicare Reform is focused on the current healthcare landscape and proposed changes for Medicare. It is critical that pharmaceutical and biotech manufacturers keep abreast of how the changing healthcare and insurance landscape will impact Medicare strategy.

Attend this elite meeting to stay on the cutting-edge of information related to Medicare Part B and D and gain an early outlook to understand the major impact of the proposed changes.”